
Chinese pharmaceutical investment group in Beijing, built on the capital markets experience of Zhongzheng Wanrong Investment Group, founded in 1991 as one of the early participants in China's capital markets. Acquires and invests in pharmaceutical companies, particularly traditional Chinese medicine makers, and directs strategy and major decisions at the companies it buys. Its controlled companies include the Shenzhen-listed Wohua Pharmaceutical (002107), Xi'an Century Shengkang and Guizhou Changsheng Pharmaceutical.
評価を残す